EVFM Stock Forecast: $EVFM RISES after partnering with a360 Media .

EVFM Stock Forecast: $EVFM RISES after partnering with a360 Media .

EVFM Stock Forecast: The stock is expected to trade at $0.90- 1.11. The overall recommendation is Buy.

EVFM Stock: Latest Price

EVFM Stock Forecast: Performance Chart

Stock Name5 Days1 Month6 Months1 Year
EVFM+24.74%-29.07%-85.35%-92.25%

EVFM Stock: Latest Tweet

Originally tweeted by Doc on Stocks (@DocOnStocks3) on August 5, 2022.

$EVFM … this had a ton of potential. Earnings beat and up 30% in AH. Ultimately no one cared today though. Stopped out w a 5% gain.

FZbGl7MXEAAAm69

EVFM Stock Forecast: Today’s Outlook

IndicatorTrend
Overall OutlookNeutral
1. Market’s WisdomPositive
1a. Market CapHigher
1b. TechnicalBuy
1c. Trading VolumeHigher
2. Crowd’s Wisdom Negative
2a. Google Search VolumeLower
2b. Social Media SentimentLower

Also Read: AGRX Stock Forecast 2022

EVFM Stock Forecast: Why is it rising?

EVFM’s stock price is soaring lately and investors are wondering what triggered it! Supreme Court’s recent judgment that strikes out Roe v. Wade is the reason. As abortions might become illegal in many states, investors have shown confidence in a growing demand for contraceptives. This brings to light this company’s non-hormonal vaginal gel which is used as a contraceptive. As it comes with no hormonal side effects and effectivity, the market welcomed it. It was approved in 2020 and since then, the product’s sales have been rising. This is a huge reversal from the dip the stock went through last year. A similar pattern was observed in Agile Therapeutics (AGRX) as well.

EVFM Stock Forecast: Latest Video

YouTube video

EVFM Stock Forecast: Latest News

  • Evofem Biosciences and Pharmacy benefit managers got into a partnership to make Phexxi more accessible. Most women covered under this plan can access the contracept without restrictions. This will lead to an increase in Phexxi prescriptions.
  • A registrational phase 3 AMPOWER trial was done for Phexxi to investigate its ability to prevent pregnancy – 99% results were in favour. This was done through a Post-hoc analysis.
  • Chief Executive Officer of Evofem Biosciences appreciates the U.S. House of representatives for passing the right of safe and easy access of contraception for women.

EVFM Stock: Technical Analysis

– Nandini Panchal

Note: Crowdwisdom360 collates Predictions and data from all over the net and has no in-house view on the likely trends in the Stocks or Crypto Coins. Please consult a registered investment advisor to guide you on your financial decisions

EVFM Stock Forecast

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Read the latest forecasts in less than 5 minutes
Choose the Topic of Interest and Subscribe to get it in your Inbox